Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, May 10, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The overlooked challenges aging men face with prostate health after 40, including frequent urination and interrupted...
-
New York, May 09, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The most common prostate health symptoms affecting men over 40Why urinary health for men declines with age—and what...
-
New York, May 05, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why prostate health becomes a critical issue for men over 40What makes Prostadine different from other prostate...
-
New York, May 01, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What Fluxactive Complete is and how it supports long-term prostate health naturallyThe full list of Fluxactive...
-
New York City, April 26, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why prostate health is vital for men over 40 and how urinary issues signal early signs of discomfortThe key...
-
Akron, April 05, 2025 (GLOBE NEWSWIRE) -- ProstaVive is re-inventing men's health, particularly prostate wellness. As men increasingly seek effective and natural solutions for maintaining their...
-
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Prevention and Treatment of Prostate Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global...
-
Pune, April 26, 2023 (GLOBE NEWSWIRE) -- As per the report by SNS Insider, the Prostate Health Market was valued at USD 34.05 billion in 2022, and it is anticipated to grow at a CAGR of 8.8% during...
-
MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related...
-
ELMWOOD PARK, N.J., June 07, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of Man Cave...